abagovomab 32
abciximab 28
abituzumab 20
abrilumab 18
actoxumab 15
adalimumab 16
aducanumab 9
afasevikumab 16
alacizumab_pegol 13
alemtuzumab 24
alirocumab 17
amatuximab 37
andecaliximab 20
anifrolumab 20
anrukinzumab 18
aprutumab 13
aprutumab_ixadotin 13
arcitumomab 23
ascrinvacumab 7
atezolizumab 15
atinumab 12
avelumab 13
basiliximab 30
bavituximab 32
begelomab 22
benralizumab 25
bevacizumab_beta 21
bezlotoxumab 15
bimagrumab 12
bleselumab 15
blinatumomab 34
blosozumab 28
bococizumab 16
brazikumab 11
brentuximab_vedotin 23
briakinumab 15
brodalumab 11
brolucizumab 27
brontictuzumab 22
burosumab 16
cabiralizumab 23
camrelizumab 14
canakinumab 26
cantuzumab_ravtansin 44
carlumab 15
carotuximab 26
cergutuzumab_amunaleukin2 25
cergutuzumab_amunaleukin 25
certolizumab_pegol 24
cetiximab 40
citatuzumab_bogatox 25
cixutumumab 24
clivatuzumab_tetraxetan 20
codrituzumab 31
conatumumab 6
concizumab 31
crenezumab 20
crizanlizumab 21
crotedumab 19
dacetuzumab 19
daclizumab 16
dalotuzumab 33
dapirolizumab_pegol 24
daratumumab 13
dectrekumab 9
demcizumab 21
denosumab 11
depatuxizumab 18
depatuxizumab_mafodotin 18
dezamizumab 18
dinutuximab 34
diridavumab 15
domagrozumab 14
drozitumab 16
duligotuzumab 18
durvalumab 10
dusigitumab 10
efalizumab 29
efungumab 30
eldelumab 11
elezanumab 15
elgemtumab 9
elotuzumab 16
emactuzumab 18
emapalumab 23
emibetuzumab 14
enavatuzumab 23
enfortumab_vedotin 11
enoblituzumab 16
enokizumab 20
enoticumab 14
ensituximab 31
eptinezumab 17
erenumab 16
etaracizumab 17
etrolizumab 21
evinacumab 21
evolocumab 14
farletuzumab 13
fasinumab 21
fezakinumab 13
fibatuzumab 8
ficlatuzumab 15
firivumab 31
flanvotumab 14
fletikumab 22
foralumab 12
foravirumab 12
fremanezumab 25
fresolimumab 17
fulranumab 20
futuximab 20
galcanezumab 17
ganitumab 26
gantenerumab 10
gemetuzumab 26
gemtuzumab2 24
gemtuzumab 24
gevokizumab 19
girentuximab 30
glembatumumab 15
glembatumumab_vedotin 15
guselkumab 19
ibalizumab 25
ibritumomab 30
icrucumab 6
idarucizumab 29
ifabotuzumab 8
imalumab 16
imgatuzumab 18
inclacumab 12
indatuximab_ravtansin 30
indusatumab 14
inebilizumab 28
intetumumab 12
iodine_girentuximab 27
ipilimumab 3
iratumumab 9
isatuximab 34
itolizumab 22
ixekizumab 32
labetuzumab_govitecan 24
lambrolizumab 25
lampalizumab 23
lanadelumab 16
landogrozumab 16
laprituximab 24
lebrikizumab 36
lendalizumab 21
lenzilumab 13
lifastuzumab_vedotin 22
ligelizumab 21
lilotomab 37
lirilumab 17
lodelcizumab 15
lokivetmab 24
lorvotuzumab_mertansin 23
lucatumumab 26
lumretuzumab 14
lupartumab 8
lutikizumab 19
margetuximab 33
milatuzumab 33
mirvetuximab 32
mirvetuximab_soravtansin 32
modotuximab 33
mogamulizumab 32
monalizumab 16
motavizumab 27
moxetumomab_pasudotox 28
namilumab 14
naratuximab 23
naratuximab_emtansin 23
narnatumab 13
navicixizumab2 24
navicixizumab 22
navivumab 34
necitumumab 9
nemolizumab 22
nesvacumab 13
nivolumab 12
obiltoxaximab 22
obinutuzumab 35
ocaratuzumab 25
ofatumumab 14
olaratumab 18
olokizumab 25
omalizumab 20
onartuzumab 20
ontuxizumab 24
opicinumab 13
orticumab 9
otelixizumab 35
oxelumab 11
ozanezumab 26
pamrevlumab 10
panobacumab 24
parsatuzumab 22
pasotuxizumab 20
pateclizumab 14
patritumab 16
pembrolizumab 25
perakizumab 18
pidilizumab 18
pinatuzumab_vedotin 17
plozalizumab 31
pogalizumab 22
polatuzumab_vedotin 19
ponezumab 33
prezalumab 12
pritoxaximab 35
quilizumab 20
racotumomab 22
radretumab 14
ralpancizumab 20
ramucirumab 13
ranevetmab 18
ranibizumab 23
refanezumab 24
remtolumab 17
rilotumumab 15
rinucumab 18
risankizumab 35
rituximab 20
rivabazumab 13
robatumumab 20
roledumab 23
romosozumab 20
rontalizumab 19
rosmantuzumab 19
rozanolixizumab 19
sacituzumab 22
sacituzumab_govitecan 22
samalizumab 24
sapelizumab 23
sarilumab 13
secukinumab 13
seribantumab 15
setoxaximab 42
sifalimumab 10
siltuximab 26
simtuzumab 26
sirukumab 12
solanezumab 23
solitomab 28
stamulumab 18
suptavumab 19
suvizumab 18
tabalumab 9
tadocizumab 12
tamtuvetmab 32
tanezumab 21
tarextumab 8
tavolixizumab 17
telisotuzumab 25
teplizumab 20
tesidolumab 18
tezepelumab 21
tigatuzumab 16
tildrakizumab 18
timolumab 15
tisotumab 12
tosatoxumab 31
tositumomab 30
tralokinumab 25
trastuzumab 20
tregalizumab 29
trevogrumab 12
ublituximab 30
urelumab 15
ustekinumab 24
utomilumab 27
vadastuximab 21
vadastuximab_talirin 21
vandortuzumab_vedotin 14
vantictumab 18
vanucizumab2 21
vanucizumab 26
varlilumab 12
vatelizumab 17
vedolizumab 26
veltuzumab 15
vesencumab 13
vorsetuzumab 17
vorsetuzumab_mafodotin 17
vunakizumab 32
xentuzumab 16
zatuximab 33
